Amgen to Present at the Thomas Weisel Healthcare Conference
09 September 2009 - 7:02AM
PR Newswire (US)
THOUSAND OAKS, Calif., Sept. 8 /PRNewswire-FirstCall/ -- Amgen
(NASDAQ: AMGN) will participate in the Thomas Weisel Healthcare
Conference on Friday, Sept. 11, 2009, at the Four Seasons in
Boston, Mass. beginning at 8:35 a.m. Eastern Time. Roy Baynes, M.D.
Ph.D., vice president of Global Development for Amgen, will present
at the conference. Live audio of the presentation will be available
over the Internet and can be accessed from Amgen's Web site,
http://www.amgen.com/, under Investors. Information regarding
presentation time, webcast availability, and webcast links are
available on Amgen's Investor Relations Events Calendar. About
Amgen Amgen discovers, develops, manufactures and delivers
innovative human therapeutics. A biotechnology pioneer since 1980,
Amgen was one of the first companies to realize the new science's
promise by bringing safe and effective medicines from lab, to
manufacturing plant, to patient. Amgen therapeutics have changed
the practice of medicine, helping millions of people around the
world in the fight against cancer, kidney disease, rheumatoid
arthritis, and other serious illnesses. With a deep and broad
pipeline of potential new medicines, Amgen remains committed to
advancing science to dramatically improve people's lives. To learn
more about our pioneering science and our vital medicines, visit
http://www.amgen.com/. CONTACT: Amgen, Thousand Oaks David Polk,
805-447-4613 (media) Arvind Sood, 805-447-1060 (investors) (Logo:
http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)
http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO
http://photoarchive.ap.org/ DATASOURCE: Amgen CONTACT: media, David
Polk, +1-805-447-4613, or investors, Arvind Sood, +1-805-447-1060,
both of Amgen, Thousand Oaks Web Site: http://www.amgen.com/
Copyright